{"transactions":[{"id":702065,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-29T00:31:10.000Z","date":"2026-07-26","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025."}],"balance_after":38749,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0000897069-26-001560","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706926001560/form4.xml","form_type":"4"}},{"id":722641,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2026-06-30T20:49:50.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":false,"shares":203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Distribution of time-based service award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Distribution of time-based service award."}],"balance_after":5249,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":203},"source":{"system":"sec-edgar","filing":"0000897069-26-001472","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706926001472/form4.xml","form_type":"4"}},{"id":722640,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-30T20:49:50.000Z","date":"2026-06-26","kind":"exercise","planned":false,"acquired":true,"shares":203,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Distribution of time-based service award."}],"balance_after":353,"source":{"system":"sec-edgar","filing":"0000897069-26-001472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706926001472/form4.xml","form_type":"4"}},{"id":1018295,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-10-15T20:16:36.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants are fully vested."}],"balance_after":750000,"derivative":{"exercise_price":0.8,"exercise_date":"2025-07-31","expiration_date":"2030-07-31","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001731122-25-001383","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112225001383/ownership.xml","form_type":"4"}},{"id":1024241,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-10-03T20:34:50.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years."}],"balance_after":300000,"derivative":{"exercise_price":0.198,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000897069-25-001555","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925001555/form4.xml","form_type":"4"}},{"id":1024240,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-10-03T20:34:50.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on October 1, 2026, and one-thirty-sixth each month thereafter until fully vested on October 1, 2028."}],"balance_after":100000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000897069-25-001555","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925001555/form4.xml","form_type":"4"}},{"id":1080515,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2025-07-28T20:16:24.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":175299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan (\"Omnibus Plan\"), of which 125,999 shares are subject to stockholder approval of the revised Omnibus Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements."}],"balance_after":206505,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":175299},"source":{"system":"sec-edgar","filing":"0000897069-25-001205","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925001205/form4.xml","form_type":"4"}},{"id":1263358,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-02-18T22:59:22.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Directed Trust Company FBO Justin Yorke IRA"},"balance_after":6200,"derivative":{"exercise_price":0.65,"exercise_date":"2025-01-29","expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":6200},"source":{"system":"sec-edgar","filing":"0000897069-25-000296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925000296/form4.xml","form_type":"4/A","original_submission_date":"2025-01-29"}},{"id":1263357,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Warrants","published_at":"2025-02-18T22:59:22.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":12400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Directed Trust Company FBO Justin Yorke IRA"},"balance_after":12400,"derivative":{"exercise_price":0.65,"exercise_date":"2025-01-29","expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":12400},"source":{"system":"sec-edgar","filing":"0000897069-25-000296","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925000296/form4.xml","form_type":"4/A","original_submission_date":"2025-01-29"}},{"id":1289246,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-31T22:06:27.000Z","date":"2025-01-27","kind":"purchase","planned":false,"acquired":true,"shares":12400,"price":0.7975,"value":9889.0,"ownership":{"direct":false,"nature":"By Directed Trust Company FBO Justin Yorke IRA"},"balance_after":12400,"source":{"system":"sec-edgar","filing":"0000897069-25-000153","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706925000153/form4.xml","form_type":"4"}},{"id":1403307,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2024-09-18T20:51:26.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":31206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements."}],"balance_after":31206,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":31206},"source":{"system":"sec-edgar","filing":"0000897069-24-001866","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706924001866/form4.xml","form_type":"4"}},{"id":1664925,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-31T21:34:20.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":8000,"price":2.693,"value":21544.0,"ownership":{"direct":false,"nature":"By Richland Fund, LLC"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":31232,"source":{"system":"sec-edgar","filing":"0000897069-24-000227","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706924000227/form4.xml","form_type":"4"}},{"id":1728427,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-28T21:13:39.000Z","date":"2023-11-21","kind":"other","planned":false,"acquired":false,"shares":55267,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Richland Fund, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer of shares to a fund that the Reporting Person does not manage. As a result, the reporting person is no longer deemed to be the beneficial owner of such shares."}],"balance_after":464623,"source":{"system":"sec-edgar","filing":"0000897069-23-001674","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001674/form4.xml","form_type":"4"}},{"id":1756151,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-23T21:31:03.000Z","date":"2023-10-12","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0.3,"value":1800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amendment filed solely to correct the amount directly owned reported on the Form 4 filed October 12, 2023 and the Form 4 filed on October 10/10/2023."}],"balance_after":74729,"source":{"system":"sec-edgar","filing":"0000897069-23-001499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001499/form4.xml","form_type":"4/A","original_submission_date":"2023-10-12"}},{"id":1761033,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-12T21:56:56.000Z","date":"2023-10-12","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0.3,"value":1800.0,"ownership":{"direct":true},"balance_after":75729,"source":{"system":"sec-edgar","filing":"0000897069-23-001462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001462/form4.xml","form_type":"4"}},{"id":1762424,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-10T20:58:16.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0.21,"value":2520.0,"ownership":{"direct":true},"balance_after":69729,"source":{"system":"sec-edgar","filing":"0000897069-23-001440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001440/form4.xml","form_type":"4"}},{"id":1824082,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2023-07-24T22:35:50.000Z","date":"2023-06-27","kind":"grant","planned":false,"acquired":true,"shares":101365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders."}],"balance_after":101365,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":101365},"source":{"system":"sec-edgar","filing":"0000897069-23-001004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001004/form4.xml","form_type":"4"}},{"id":1824081,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Restricted Stock","published_at":"2023-07-24T22:35:50.000Z","date":"2023-06-27","kind":"exercise","planned":false,"acquired":false,"shares":23636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting of time-based restricted shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":23636},"source":{"system":"sec-edgar","filing":"0000897069-23-001004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001004/form4.xml","form_type":"4"}},{"id":1824080,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-24T22:35:50.000Z","date":"2023-06-27","kind":"exercise","planned":false,"acquired":true,"shares":23636,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":56729,"source":{"system":"sec-edgar","filing":"0000897069-23-001004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000089706923001004/form4.xml","form_type":"4"}},{"id":1893182,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-15T20:30:50.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"expiration_date":"2033-04-05","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112223000935/ownership.xml","form_type":"4"}},{"id":2066181,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-01-04T22:49:29.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-23-000329","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761923000329/doc1.xml","form_type":"4"}},{"id":2066180,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T22:49:29.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":18208,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":33093,"source":{"system":"sec-edgar","filing":"0001567619-23-000329","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761923000329/doc1.xml","form_type":"4"}},{"id":2066179,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T22:29:25.000Z","date":"2022-08-05","kind":"exercise","acquired":true,"shares":1169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Previous filing inadvertently underreported shares beneficially owned by the reporting person."}],"balance_after":14885,"source":{"system":"sec-edgar","filing":"0001567619-23-000303","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761923000303/doc1.xml","form_type":"4/A","original_submission_date":"2022-08-09"}},{"id":2190572,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T20:31:52.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":4393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":13716,"source":{"system":"sec-edgar","filing":"0001567619-22-015312","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761922015312/doc1.xml","form_type":"4"}},{"id":2294564,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2022-04-20T01:20:39.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":18208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units vest 100% on December 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units vest 100% on December 31, 2022."}],"balance_after":19377,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":18208},"source":{"system":"sec-edgar","filing":"0001567619-22-008684","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761922008684/doc1.xml","form_type":"4"}},{"id":2307487,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T21:54:31.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":4393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":13716,"source":{"system":"sec-edgar","filing":"0001567619-22-008006","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761922008006/doc1.xml","form_type":"4"}},{"id":2312616,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-04-01T01:42:09.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.6,"expiration_date":"2026-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-22-000655","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112222000655/ownership.xml","form_type":"4"}},{"id":2420911,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-31T21:45:59.000Z","date":"2022-01-27","kind":"sale","acquired":false,"shares":1854,"price":3.3,"value":6118.2,"ownership":{"direct":false,"nature":"By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.26 to $3.37, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":532563,"source":{"system":"sec-edgar","filing":"0001567619-22-002079","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761922002079/doc1.xml","form_type":"4"}},{"id":2481853,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-07T21:36:14.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":4200,"price":4.7104,"value":19783.68,"ownership":{"direct":false,"nature":"By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.5601 to $4.80, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":534417,"source":{"system":"sec-edgar","filing":"0001567619-21-021710","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761921021710/doc1.xml","form_type":"4"}},{"id":2481852,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-07T21:36:14.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":5500,"price":4.8362,"value":26599.1,"ownership":{"direct":false,"nature":"By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.8001 to $5.01, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":538617,"source":{"system":"sec-edgar","filing":"0001567619-21-021710","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761921021710/doc1.xml","form_type":"4"}},{"id":2583207,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T20:41:08.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":1169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The previous filing overstated the number of securities directly owned by the reporting person and understated the number of securities indirectly owned by the reporting person."}],"balance_after":9323,"source":{"system":"sec-edgar","filing":"0001567619-21-016570","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761921016570/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-09"}},{"id":2609820,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-09T20:44:29.000Z","date":"2021-08-05","kind":"grant","acquired":true,"shares":1169,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of time-based restricted shares."}],"balance_after":301875,"source":{"system":"sec-edgar","filing":"0001567619-21-014756","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761921014756/doc1.xml","form_type":"4"}},{"id":2748387,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T20:33:38.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":9700,"price":9.42,"value":91374.0,"ownership":{"direct":false,"nature":"By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $9.31 to $9.50, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":248272,"source":{"system":"sec-edgar","filing":"0001567619-21-008151","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761921008151/doc1.xml","form_type":"4"}},{"id":2748386,"issuer":{"id":8210,"kind":"organization","name":"Processa Pharmaceuticals, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T20:33:38.000Z","date":"2021-04-13","kind":"sale","acquired":false,"shares":6500,"price":9.86,"value":64090.0,"ownership":{"direct":false,"nature":"By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $9.65 to $10.15, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":257972,"source":{"system":"sec-edgar","filing":"0001567619-21-008151","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000156761921008151/doc1.xml","form_type":"4"}},{"id":3003834,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:30:31.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":166666,"derivative":{"exercise_price":0.75,"exercise_date":"2022-10-15","expiration_date":"2027-10-15","underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001731122-20-001059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112220001059/ownership.xml","form_type":"4"}},{"id":3003833,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:30:31.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":166667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":166667,"derivative":{"exercise_price":0.75,"exercise_date":"2021-10-15","expiration_date":"2026-10-15","underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001731122-20-001059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112220001059/ownership.xml","form_type":"4"}},{"id":3003832,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":28202,"kind":"person","name":"Yorke Justin W","position":1,"cik":"0001361896","reported_name":"Yorke Justin W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (Right to Buy)","published_at":"2020-10-19T22:30:31.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":166667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":166667,"derivative":{"exercise_price":0.75,"exercise_date":"2020-10-16","expiration_date":"2025-10-15","underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001731122-20-001059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1361896/000173112220001059/ownership.xml","form_type":"4"}}]}